SPRAVATO® Treatment for Depression
Offered at Aria Psychiatry – Personalized Care for Treatment-Resistant Depression
At Aria Psychiatry, we proudly offer SPRAVATO® (esketamine) nasal spray, an innovative, FDA-approved treatment for adults living with treatment-resistant depression (TRD). If you've tried at least two different oral antidepressants without lasting relief, SPRAVATO® may offer a new path to healing.
What Is SPRAVATO®?
SPRAVATO® is a prescription nasal spray containing esketamine, a medication that works differently than traditional antidepressants by targeting the glutamate system in the brain. This unique mechanism can help rapidly improve symptoms of major depressive disorder (MDD) in individuals who haven't responded to other treatments.
SPRAVATO® is the only FDA-approved therapy that can be used:
As monotherapy (on its own) for treatment-resistant depression
In combination with an oral antidepressant to enhance therapeutic effects
Who Can Benefit from SPRAVATO®?
SPRAVATO® may be right for you if you:
Have major depressive disorder (MDD)
Have had inadequate response to at least two oral antidepressants
Are seeking a breakthrough treatment for severe or chronic depression
Why Choose Aria Psychiatry for SPRAVATO®?
At Aria Psychiatry, we provide SPRAVATO® in a safe, comfortable clinical setting with close monitoring by our experienced psychiatric team. Our goal is to help you feel supported and informed throughout every step of your care.
Start Your SPRAVATO® Journey Today
If you’ve struggled with treatment-resistant depression, you don’t have to go through it alone. SPRAVATO® may offer the relief you’ve been searching for.
Contact Aria Psychiatry today to schedule a consultation and see if SPRAVATO® is right for you.